Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma

Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma

Item

http://www.wikidata.org/entity/Q36950640

Q36950640

about

Chemotherapy for children with medulloblastoma Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease Development and cancer of the cerebellum Ototoxicity evaluation in medulloblastoma patients treated with involved field boost using intensity-modulated radiation therapy (IMRT): a retrospective review Central nervous system cancers Cognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches.Treatment outcomes and late toxicities in patients with embryonal central nervous system tumors Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma Advances in paediatric cancer treatment Radiation therapy quality in CCG/POG intergroup 9961: implications for craniospinal irradiation and the posterior fossa boost in future medulloblastoma trials.Pediatric brain tumors: current treatment strategies and future therapeutic approaches Brain tumors across the age spectrum: biology, therapy, and late effects.Evidence in medulloblastomas.Medulloblastoma: progress over time.Local control in non-metastatic medulloblastoma.Medulloblastoma: Molecular Classification-Based Personal Therapeutics.Proton Beam Therapy for Pediatric Brain Tumor.Adjuvant chemotherapy and overall survival in adult medulloblastoma.Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma Long-term life expectancy for children with ependymoma and medulloblastoma.Functional and neuropsychological late outcomes in posterior fossa tumors in children.Long-term outcomes of adult medulloblastoma patients treated with radiotherapy.Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.Large cell/anaplastic medulloblastoma is associated with poor prognosis-a retrospective analysis at a single institute.Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.Radiation Therapy against Pediatric Malignant Central Nervous System Tumors : Embryonal Tumors and Proton Beam Therapy.Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma.Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry

P2860

Q24186770-ECD6C861-AA32-4F46-8373-DD01276A15AC Q28288622-CE46C4EA-A0D0-43A6-B1BB-28027704DA26 Q28305235-81920944-03E6-4C91-9E67-6375579BF5EC Q33985538-102B11C2-FC82-46DF-9F7B-731D55CC2642 Q34014740-2804F369-97C3-4C0F-81F6-F7EFBF914ABB Q34021952-5A68DC4D-FDB7-4F92-9835-9691038E6486 Q34667517-886D58C9-9B0C-46FB-8229-4DCFC7C92E8B Q36437280-0D99526C-2FFF-4683-A0AF-CD2AB92EA0A8 Q36508630-EEE3E3FC-2F30-4BA8-971A-02D871B01321 Q36520680-5A769456-B1B2-453C-939E-AFE8D7F80F09 Q37533670-1109F12D-A094-438E-AC57-71D07D62F053 Q37643976-4E6CE41C-16C2-4327-ADFB-9C6A949F4F93 Q37750058-64F4F0F5-270E-4E49-85E1-8020B286DD73 Q38002192-041B5692-F358-47E7-BB46-0E83C36C0EF4 Q38225901-BAA3167A-26A8-43D4-9BA3-E2BEC8D92836 Q39225738-B9DDC609-2705-4620-BC31-5AD3F3797079 Q39365632-180BDD26-7E70-4B8B-B15A-3FFC345F67CC Q39475097-4157EFDB-83D1-4D1E-A5B8-8D510E5B8DBB Q39786623-2D90EF19-72DF-48DD-BC86-F62BB33C9E35 Q40897111-CABBC6E8-CF87-4B63-9B91-A12F9F6B3188 Q41386758-56E8EBCA-A3D3-4F24-9D08-08FA4A73CAEC Q46018019-9F5E75C0-C40F-4DAC-816E-16A00C2F1A31 Q47363064-B236D94F-C0D2-4651-B66C-B13A5D31D8EB Q47376346-C2C90395-C813-4384-BE63-8C0A9684241E Q48100021-E303B7D9-9485-4633-9D63-60C75D88CA99 Q55325381-6895EB80-16D4-4BD4-8612-30F327EE0843 Q55463859-77C2DE7E-BBA0-424B-A225-4DCFFD638350 Q57174479-A1D02C8D-9E51-4EEE-80AE-251B3E00E0A7

P2860

Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma

Item

http://www.wikidata.org/entity/Q36950640

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Multi-institution prospective ...... r average-risk medulloblastoma

@en

type

Item

label

Multi-institution prospective ...... r average-risk medulloblastoma

@en

prefLabel

Multi-institution prospective ...... r average-risk medulloblastoma

@en

P1476

Multi-institution prospective ...... r average-risk medulloblastoma

@en

P2093

Amar Gajjar

http://www.w3.org/2001/XMLSchema#string

Dana Wallace

http://www.w3.org/2001/XMLSchema#string

David M Ashley

http://www.w3.org/2001/XMLSchema#string

Larry E Kun

http://www.w3.org/2001/XMLSchema#string

Maree Sexton

http://www.w3.org/2001/XMLSchema#string

Matthew J Krasin

http://www.w3.org/2001/XMLSchema#string

Murali M Chintagumpala

http://www.w3.org/2001/XMLSchema#string

Shiao Y Woo

http://www.w3.org/2001/XMLSchema#string

Stewart J Kellie

http://www.w3.org/2001/XMLSchema#string

Thomas E Merchant

http://www.w3.org/2001/XMLSchema#string

P2860

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

Early vasculopathy following radiation in a child with medulloblastoma.

Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP).

Medulloblastoma: present concepts of stratification into risk groups.

Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure.

Late neurocognitive sequelae in survivors of brain tumours in childhood.

Preliminary results of conformal radiation therapy for medulloblastoma

Postradiation spinal deformity.

Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma.

Prognostic factors and secondary malignancies in childhood medulloblastoma.

P304

782-787

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2007.07.2342

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5951419

http://www.w3.org/2001/XMLSchema#string

P698

17892918

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma

P932

2716663

http://www.w3.org/2001/XMLSchema#string

Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma

about

P2860

P2860

Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932